Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid

Brain Research

Volumn 1359, Issue , 2010, Pages 1-13

  Gonzalez, Ana Maria ^a   Leadbeater, Wendy ^a   Podvin, Sonia ^b   Borboa, Alexandra ^b   Burg, Michael ^b   Sawada, Ritsuko ^b   Rayner, James ^a   Sims, Karen ^a   Terasaki, Tetsuya ^c   Johanson, Conrad ^d   Stopa, Edward ^d   Eliceiri, Brian ^b   Baird, Andrew ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d BROWN UNIVERSITY   (United States)

Author keywords

Cerebrospinal fluid; Endocytosis; Epidermal growth factor; Epithelial cell; Gene delivery; Phage

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; BLOOD BRAIN BARRIER; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHOROID PLEXUS; CYTOMEGALOVIRUS; EPITHELIUM CELL; EXPLANT; GENE EXPRESSION; GENE TARGETING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BACTERIOPHAGES; CEREBROSPINAL FLUID; CHOROID PLEXUS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; MICE; RATS; TRANSDUCTION, GENETIC;

CYTOMEGALOVIRUS;

EID: 77958020305     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.08.044     Document Type: Article

References (54)

1. Y. Aida, and M.J. Pabst Removal of endotoxin from protein solutions by phase separation using Triton X-114 J. Immunol. Methods 132 1990 191 195
2. G. Bajocchi, S.H. Feldman, R.G. Crystal, and A. Mastrangeli Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors Nat. Genet. 3 1993 229 234
3. M.A. Barry, W.J. Dower, and S.A. Johnston Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries Nat. Med. 2 1996 299 305
4. U. Bickel, T. Yoshikawa, and W.M. Pardridge Delivery of peptides and proteins through the blood-brain barrier Adv. Drug Deliv. Rev. 46 2001 247 279
5. P.D. Brown, S.L. Davies, T. Speake, and I.D. Millar Molecular mechanisms of cerebrospinal fluid production Neuroscience 129 2004 957 970
6. M. Burg, E.P. Ravey, M. Gonzales, E. Amburn, P.H. Faix, A. Baird, and D. Larocca Selection of internalizing ligand-display phage using rolling circle amplification for phage recovery DNA Cell Biol. 23 2004 457 462
7. M.A. Burg, K. Jensen-Pergakes, A.M. Gonzalez, P. Ravey, A. Baird, and D. Larocca Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells Cancer Res. 62 2002 977 981
8. G.A. Camihort, C.B. Herenu, G.C. Luna, S.S. Rodriguez, M.I. Bracamonte, R.G. Goya, and G.M. Console Morphological changes induced by insulin-like growth factor-I gene therapy in pituitary cell populations in experimental prolactinomas Cells Tissues Organs 191 2010 316 325
9. E. Carro, A. Nunez, S. Busiguina, and I. Torres-Aleman Circulating insulin-like growth factor I mediates effects of exercise on the brain J. Neurosci. 20 2000 2926 2933
10. E. Carro, C. Spuch, J.L. Trejo, D. Antequera, and I. Torres-Aleman Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I J. Neurosci. 25 2005 10884 10893
11. A.I. Danilov, W. Gomes-Leal, H. Ahlenius, Z. Kokaia, E. Carlemalm, and O. Lindvall Ultrastructural and antigenic properties of neural stem cells and their progeny in adult rat subventricular zone Glia 57 2009 136 152
12. J. Guan, S.J. Skinner, E.J. Beilharz, K.M. Hua, S. Hodgkinson, P.D. Gluckman, and C.E. Williams The movement of IGF-I into the brain parenchyma after hypoxic-ischaemic injury NeuroReport 7 1996 632 636
13. J. Guan, O.T. Miller, K.M. Waugh, D.C. McCarthy, and P.D. Gluckman Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats Neuroscience 105 2001 299 306
14. W.A. Hall, M.J. Merrill, S. Walbridge, and R.J. Youle Epidermal growth factor receptors on ependymomas and other brain tumors J. Neurosurg. 72 1990 641 646
15. R.P. Harbottle, R.G. Cooper, S.L. Hart, A. Ladhoff, T. McKay, A.M. Knight, E. Wagner, A.D. Miller, and C. Coutelle An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery Hum. Gene Ther. 9 1998 1037 1047
16. C.B. Herenu, C. Cristina, O.J. Rimoldi, D. Becu-Villalobos, V. Cambiaggi, E.L. Portiansky, and R.G. Goya Restorative effect of insulin-like growth factor-I gene therapy in the hypothalamus of senile rats with dopaminergic dysfunction Gene Ther. 14 2007 237 245
17. C.B. Herenu, W.E. Sonntag, G.R. Morel, E.L. Portiansky, and R.G. Goya The ependymal route for insulin-like growth factor-1 gene therapy in the brain Neuroscience 163 2009 442 447
18. K. Hosoya, S. Hori, S. Ohtsuki, and T. Terasaki A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat Adv. Drug Deliv. Rev. 56 2004 1875 1885
19. V.V. Ivanenkov, and A.G. Menon Peptide-mediated transcytosis of phage display vectors in MDCK cells Biochem. Biophys. Res. Commun. 276 2000 251 257
20. C.E. Johanson, J.A. Duncan, E.G. Stopa, and A. Baird Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route Pharm. Res. 22 2005 1011 1037
21. P.D. Kassner, M.A. Burg, A. Baird, and D. Larocca Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells Biochem. Biophys. Res. Commun. 264 1999 921 928
22. T. Kitazawa, K. Hosoya, M. Watanabe, T. Takashima, S. Ohtsuki, H. Takanaga, M. Ueda, N. Yanai, M. Obinata, and T. Terasaki Characterization of the amino acid transport of new immortalized choroid plexus epithelial cell lines: a novel in vitro system for investigating transport functions at the blood-cerebrospinal fluid barrier Pharm. Res. 18 2001 16 22
23. E. Koivunen, W. Arap, D. Rajotte, J. Lahdenranta, and R. Pasqualini Identification of receptor ligands with phage display peptide libraries J. Nucl. Med. 40 1999 883 888
24. M.G. Kolonin, P.K. Saha, L. Chan, R. Pasqualini, and W. Arap Reversal of obesity by targeted ablation of adipose tissue Nat. Med. 10 2004 625 632
25. P.E. Kuhn, and M.W. Miller c-neu oncoprotein in developing rostral cerebral cortex: relationship to epidermal growth factor receptor J. Comp. Neurol. 372 1996 189 203
26. D. Larocca, A. Witte, W. Johnson, G.F. Pierce, and A. Baird Targeting bacteriophage to mammalian cell surface receptors for gene delivery Hum. Gene Ther. 9 1998 2393 2399
27. D. Larocca, K. Jensen-Pergakes, M.A. Burg, and A. Baird Gene transfer using targeted filamentous bacteriophage Methods Mol. Biol. 185 2002 393 401
28. X. Li, P. Stuckert, I. Bosch, J.D. Marks, and W.A. Marasco Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells Cancer Gene Ther. 8 2001 555 565
29. P.G. McMenamin Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations J. Comp. Neurol. 405 1999 553 562
30. A. Misra, S. Ganesh, A. Shahiwala, and S.P. Shah Drug delivery to the central nervous system: a review J. Pharm. Pharm. Sci. 6 2003 252 273
31. J.D. Mount, T.I. Samoylova, N.E. Morrison, N.R. Cox, H.J. Baker, and V.A. Petrenko Cell targeted phagemid rescued by preselected landscape phage Gene 341 2004 59 65
32. A. Muruganandam, J. Tanha, S. Narang, and D. Stanimirovic Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium FASEB J. 16 2002 240 242
33. E. Neuwelt, N.J. Abbott, L. Abrey, W.A. Banks, B. Blakley, T. Davis, B. Engelhardt, P. Grammas, M. Nedergaard, J. Nutt, W. Pardridge, G.A. Rosenberg, Q. Smith, and L.R. Drewes Strategies to advance translational research into brain barriers Lancet Neurol. 7 2008 84 96
34. W.M. Pardridge Drug targeting to the brain Pharm. Res. 24 2007 1733 1744
35. W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 2007 54 61
36. R. Pasqualini, and E. Ruoslahti Tissue targeting with phage peptide libraries Mol. Psychiatry 1 1996 423
37. R. Pasqualini, and E. Ruoslahti Searching for a molecular address in the brain Mol. Psychiatry 1 1996 421 422
38. R. Pasqualini, and E. Ruoslahti Organ targeting in vivo using phage display peptide libraries Nature 380 1996 364 366
39. R. Pasqualini Vascular targeting with phage peptide libraries Q. J. Nucl. Med. 43 1999 159 162
40. M.M. Patel, B.R. Goyal, S.V. Bhadada, J.S. Bhatt, and A.F. Amin Getting into the brain: approaches to enhance brain drug delivery CNS Drugs 23 2009 35 58
41. M.A. Poul, and J.D. Marks Targeted gene delivery to mammalian cells by filamentous bacteriophage J. Mol. Biol. 288 1999 203 211
42. D. Rajotte, W. Arap, M. Hagedorn, E. Koivunen, R. Pasqualini, and E. Ruoslahti Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display J. Clin. Invest. 102 1998 430 437
43. E.M. Rodriguez, J.L. Blazquez, and M. Guerra The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid Peptides 31 2010 757 776
44. F. Schlachetzki, Y. Zhang, R.J. Boado, and W.M. Pardridge Gene therapy of the brain: the trans-vascular approach Neurology 62 2004 1275 1281
45. G.P. Smith, and V.A. Petrenko Phage display Chem. Rev. 97 1997 391 410
46. R.G. Soderquist, and M.J. Mahoney Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics Expert Opin. Drug Deliv. 7 2010 285 293
47. E.G. Stopa, T.M. Berzin, S. Kim, P. Song, V. Kuo-LeBlanc, M. Rodriguez-Wolf, A. Baird, and C.E. Johanson Human choroid plexus growth factors: what are the implications for CSF dynamics in Alzheimer's disease? Exp. Neurol. 167 2001 40 47
48. J. Tanha, A. Muruganandam, and D. Stanimirovic Phage display technology for identifying specific antigens on brain endothelial cells Methods Mol. Med. 89 2003 435 449
49. M. Trepel, W. Arap, and R. Pasqualini Exploring vascular heterogeneity for gene therapy targeting Gene Ther. 7 2000 2059 2060
50. J.G. Veening, and H.P. Barendregt The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review Cerebrospinal Fluid Res. 7 2010 1
51. B. Vigh, and I. Vigh-Teichmann Actual problems of the cerebrospinal fluid-contacting neurons Microsc. Res. Tech. 41 1998 57 83
52. B. Vigh, M.J. Manzano e Silva, C.L. Frank, C. Vincze, S.J. Czirok, A. Szabo, A. Lukats, and A. Szel The system of cerebrospinal fluid-contacting neurons. Its supposed role in the nonsynaptic signal transmission of the brain Histol. Histopathol. 19 2004 607 628
53. C.L. Vitiello, C.R. Merril, and S. Adhya An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold Virus Res. 114 2005 101 103
54. Y.L. Yip, N.J. Hawkins, G. Smith, and R.L. Ward Biodistribution of filamentous phage-Fab in nude mice J. Immunol. Methods. 225 1999 171 178